Testicular wedge biopsy for fertility preservation in children at significant risk for azoospermia after gonadotoxic therapy |
| |
Authors: | Kristine S. Corkum Timothy B. Lautz Emilie K. Johnson Molly B. Reimann Amy L. Walz Barbara A. Lockart Robert E. Brannigan Hanna ValliPulaski Kyle E. Orwig Erin E. Rowell |
| |
Affiliation: | 1. Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA;2. Division of Pediatric Surgery, Ann and Robert H. Lurie Children''s Hospital of Chicago, Chicago, IL, USA;3. Division of Urology, Ann and Robert H. Lurie Children''s Hospital of Chicago, Chicago, IL, USA;4. Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA;5. Division of Hematology, Oncology, and Stem Cell Transplantation, Ann and Robert H. Lurie Children''s Hospital of Chicago, Chicago, IL, USA;6. Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA |
| |
Abstract: | Background/purposeTesticular tissue cryopreservation (TTC) provides an experimental option for fertility preservation for male children at significant risk for azoospermia owing to high-risk gonadotoxic treatments.MethodsA single institution, retrospective review of TTC cases from 2015 to 2017. Children at significant risk for azoospermia were eligible for study inclusion. A unilateral wedge biopsy of the testis was performed for TTC.ResultsTTC was performed in 23 patients. Average age was 10 years old (5 months to 18 years). Diagnoses included solid tumor (74%, n = 17), hematologic malignancy (17%, n = 4), and benign hematologic disease (13%, n = 3). Six patients had TTC at the time of disease relapse. Nine patients were referred for TTC prior to stem cell transplantation. The majority (70%, n = 16) of patients had an additional procedure at the time of TTC. One patient developed postoperative scrotal cellulitis that was treated with antibiotics. The majority of patients (96%, n = 22) had normal testicular tissue with the presence of germ cells on histopathological analysis. Median time to start of medical therapy was seven days with no unanticipated treatment delays.ConclusionsTesticular wedge biopsy for TTC can be performed safely, coordinated with other necessary procedures, and does not delay the start of treatment. TTC remains an experimental option for fertility preservation for children, as no spermatogenic recovery or pregnancies from cryopreserved testicular tissues have been reported to date.Level of evidenceIV. |
| |
Keywords: | Corresponding author at: 225 East Chicago Avenue, Box 63, Chicago, Illinois, USA 60611. Testicular tissue cryopreservation Children Wedge biopsy Fertility preservation |
本文献已被 ScienceDirect 等数据库收录! |
|